The Paradox of Biotechnology Value Investing: Assessing Worth Could Be More than Just Conjecture if the Right Tools Are Used

摘要

On the surface, biotechnology and value do not have much in common. Biotech companies lack predictable cash flows and calculable margins of safety; the sector is one of the market's most volatile. Early-stage biotech companies are really two businesse